Lupin launches fixed-dose triple drug combination to manage asthma January 5, 2023 | No Comments The product will help in the management of inadequately controlled asthma by improving lung function, providing better symptom control and reducing exacerbations. Share this:TwitterFacebookLike this:Like Loading... Tags: Analysis, IPO News, latest stock market news, News, Share Market Live Charts, Share Market Today